Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ovarian Neoplasms

  Free Subscription


Articles published in Am J Obstet Gynecol

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    August 2022
  1. BODURTHA SMITH AJ, Alvarez R, Heintz J, Haggerty A, et al
    Disparities in Biomarker Testing in Ovarian Cancer: A Real-World Analysis.
    Am J Obstet Gynecol. 2022 Aug 22. pii: S0002-9378(22)00686.
    PubMed    


    June 2022
  2. MORUZZI MC, Bolomini G, Esposito R, Mascilini F, et al
    Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer.
    Am J Obstet Gynecol. 2022 Jun 22. pii: S0002-9378(22)00367.
    PubMed     Abstract available


    May 2022
  3. CHAMBERS LM, O'Malley DM, Coleman RL, Herzog TJ, et al
    Is there a "Low Risk" Patient Population in Advanced Epithelial Ovarian Cancer?: A Critical Analysis.
    Am J Obstet Gynecol. 2022 May 28. pii: S0002-9378(22)00412.
    PubMed     Abstract available


    April 2022
  4. HUEPENBECKER SP, Fu S, Sun CC, Zhao H, et al
    Medicaid expansion and 2-year survival in women with gynecologic cancer: a difference-in-difference analysis.
    Am J Obstet Gynecol. 2022 Apr 29. pii: S0002-9378(22)00326.
    PubMed     Abstract available


  5. ORLANDO MS, Cadish LA, Shepherd JP, Falcone T, et al
    Salpingo-Oophorectomy or Surveillance for Ovarian Endometrioma in Asymptomatic Premenopausal Women: a Cost-Effectiveness Analysis.
    Am J Obstet Gynecol. 2022 Apr 28. pii: S0002-9378(22)00324.
    PubMed     Abstract available


  6. KARIA PS, Huang Y, Tehranifar P, Visvanathan K, et al
    Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
    Am J Obstet Gynecol. 2022 Apr 27. pii: S0002-9378(22)00317.
    PubMed     Abstract available


  7. HUO N, Smith CY, Gazzuola Rocca L, Rocca WA, et al
    Risk of de novo cancer after premenopausal bilateral oophorectomy.
    Am J Obstet Gynecol. 2022;226:539.
    PubMed     Abstract available


    February 2022
  8. MAI PL, Miller A, Black A, Falk RT, et al
    Effect of Risk-Reducing Salpingo-Oophorectomy on Sex-Steroid Hormone Serum Levels among Post-Menopausal Women: An NRG Oncology/GOG Study.
    Am J Obstet Gynecol. 2022 Feb 22. pii: S0002-9378(22)00124.
    PubMed     Abstract available


    January 2022
  9. XHOLLI A, Kratochwila C, Ferrero S, Moioli M, et al
    Role of three-dimensional ultrasound in ovarian cancer staging.
    Am J Obstet Gynecol. 2022 Jan 6. pii: S0002-9378(22)00001.
    PubMed    


    November 2021
  10. SMITH MJ, Gerber D, Olsen A, Khouri OR, et al
    Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
    Am J Obstet Gynecol. 2021;225:508.
    PubMed     Abstract available


  11. COREY L, Cote ML, Ruterbusch JJ, Winer I, et al
    Disparities in Adjuvant Treatment of High-Grade Endometrial Cancer in the Medicare Population.
    Am J Obstet Gynecol. 2021 Nov 1. pii: S0002-9378(21)01179.
    PubMed     Abstract available


    October 2021
  12. CHI-HAU C
    Decidualized ovarian endometrioma.
    Am J Obstet Gynecol. 2021 Oct 7. pii: S0002-9378(21)01104.
    PubMed    


  13. MANDELBAUM RS, Matsuzaki S, Sangara RN, Klar M, et al
    Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
    Am J Obstet Gynecol. 2021;225:399.
    PubMed     Abstract available


    September 2021
  14. CUSIMANO MC, Ferguson SE, Moineddin R, Chiu M, et al
    Ovarian Cancer Incidence and Death in Average-Risk Women Undergoing Bilateral Salpingo-Oophorectomy at Benign Hysterectomy.
    Am J Obstet Gynecol. 2021 Sep 23. pii: S0002-9378(21)01048.
    PubMed     Abstract available


  15. VAN LIESHOUT LAM, Gelderblom ME, DE Hullu JA, The R, et al
    Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy.
    Am J Obstet Gynecol. 2021 Sep 15. pii: S0002-9378(21)01007.
    PubMed     Abstract available


    June 2021
  16. MARCHAND G, Mills K, Ware K
    Reply to a question regarding ovarian cancer prevention with partial salpingectomy versus complete.
    Am J Obstet Gynecol. 2021 Jun 30. pii: S0002-9378(21)00769.
    PubMed    


    May 2021
  17. MARCHOCKI Z, Cusimano MC, Clarfield L, Rachel Kim S, et al
    Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics.
    Am J Obstet Gynecol. 2021 May 28. pii: S0002-9378(21)00602.
    PubMed     Abstract available


  18. VAN WEELDEN WJ, Lalisang RI, Bulten J, Lindemann K, et al
    IMPACT OF HORMONAL BIOMARKERS ON RESPONSE TO HORMONAL THERAPY IN ADVANCED AND RECURRENT ENDOMETRIAL CANCER.
    Am J Obstet Gynecol. 2021 May 18. pii: S0002-9378(21)00554.
    PubMed     Abstract available


  19. SUH-BURGMANN E, Brasic N, Jha P, Hung YY, et al
    Ultrasound characteristics of early stage high-grade serous ovarian cancer.
    Am J Obstet Gynecol. 2021 May 13. pii: S0002-9378(21)00551.
    PubMed     Abstract available


    March 2021
  20. NAUMANN RW, Hughes BN, Brown J, Drury LK, et al
    The Impact of Opportunistic Salpingectomy on Ovarian Cancer Mortality and Healthcare Costs: A Call For Universal Insurance Coverage.
    Am J Obstet Gynecol. 2021 Mar 30. pii: S0002-9378(21)00212.
    PubMed     Abstract available


    February 2021
  21. HARRISON RF, Fu S, Sun CC, Zhao H, et al
    Patient cost-sharing during poly(ADP-ribose) polymerase inhibitor treatment in ovarian cancer.
    Am J Obstet Gynecol. 2021 Feb 4. pii: S0002-9378(21)00086.
    PubMed     Abstract available


    January 2021
  22. SCHRIJVER LH, Antoniou AC, Olsson H, Mooij TM, et al
    Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    Am J Obstet Gynecol. 2021 Jan 22. pii: S0002-9378(21)00038.
    PubMed     Abstract available


  23. MATSUO K, Mandelbaum RS, Matsuzaki S, Klar M, et al
    Ovarian conservation for young women with early-stage low-grade endometrial cancer: A proposal for a two-step approach.
    Am J Obstet Gynecol. 2021 Jan 4. pii: S0002-9378(20)32630.
    PubMed     Abstract available


    December 2020
  24. MASCIULLO V, Trivellizzi N, Zannoni G, Catena U, et al
    Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
    Am J Obstet Gynecol. 2020 Dec 29. pii: S0002-9378(20)32627.
    PubMed     Abstract available


    August 2020
  25. SAMIMI G, Sathyamoorthy N, Tingen CM, Mazloomdoost D, et al
    Report of NCI and NICHD-Sponsored Workshop: Gynecology and Women's Health-Benign Conditions and Cancer.
    Am J Obstet Gynecol. 2020 Aug 21. pii: S0002-9378(20)30877.
    PubMed     Abstract available


  26. WESTIN SN, Fellman B, Sun CC, Broaddus RR, et al
    Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer.
    Am J Obstet Gynecol. 2020 Aug 14. pii: S0002-9378(20)30861.
    PubMed     Abstract available


  27. ALBRIGHT BB, Nasioudis D, Craig S, Moss HA, et al
    Impact of Medicaid expansion on women with gynecologic cancer: A difference-in-difference analysis.
    Am J Obstet Gynecol. 2020 Aug 7. pii: S0002-9378(20)30835.
    PubMed     Abstract available


    July 2020
  28. PADILLA-ISERTE P, Lago V, Tauste C, DIaz-Feijoo B, et al
    Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.
    Am J Obstet Gynecol. 2020 Jul 18. pii: S0002-9378(20)30744.
    PubMed     Abstract available


  29. FERRARI F, Forte S, Sbalzer N, Zizioli V, et al
    Validation of an enhanced recovery after surgery protocol in gynecological surgery: an Italian randomized study.
    Am J Obstet Gynecol. 2020 Jul 8. pii: S0002-9378(20)30720.
    PubMed     Abstract available


    May 2020
  30. CHAMBERS LM, Morton M, Lampert E, Yao M, et al
    Use of Prophylactic Closed Incision Negative Pressure Therapy Is Associated with Reduced Surgical Site Infections in Gynecologic Oncology Patients Undergoing Laparotomy.
    Am J Obstet Gynecol. 2020 May 14. pii: S0002-9378(20)30536.
    PubMed     Abstract available


    April 2020
  31. MANDELBAUM RS, Adams CL, Yoshihara K, Nusbaum DJ, et al
    The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecological disease in the United States.
    Am J Obstet Gynecol. 2020 Apr 30. pii: S0002-9378(20)30514.
    PubMed     Abstract available


    March 2020
  32. MILLER H, Matsuo K
    A cesarean delivery sequela: Scar rupture and tumor spill during laparoscopic hysterectomy for endometrial cancer.
    Am J Obstet Gynecol. 2020 Mar 18. pii: S0002-9378(20)30337.
    PubMed    


  33. KASPERS M, Llamocca E, Quick A, Dholakia J, et al
    Black and Hispanic women are less likely than White women to receive guideline-concordant endometrial cancer treatment.
    Am J Obstet Gynecol. 2020 Mar 3. pii: S0002-9378(20)30232.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: